1. Home
  2. WRAP vs TLSA Comparison

WRAP vs TLSA Comparison

Compare WRAP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wrap Technologies Inc.

WRAP

Wrap Technologies Inc.

N/A

Current Price

$1.60

Market Cap

106.5M

Sector

Industrials

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$0.83

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WRAP
TLSA
Founded
2016
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.5M
145.1M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
WRAP
TLSA
Price
$1.60
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
695.9K
687.3K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,672,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.66
N/A
52 Week Low
$1.04
$0.87
52 Week High
$3.23
$2.35

Technical Indicators

Market Signals
Indicator
WRAP
TLSA
Relative Strength Index (RSI) 46.18 32.91
Support Level $1.60 N/A
Resistance Level $1.68 $1.20
Average True Range (ATR) 0.11 0.08
MACD 0.01 -0.02
Stochastic Oscillator 35.29 12.73

Price Performance

Historical Comparison
WRAP
TLSA

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: